Menard Financial Group’s Teladoc Health TDOC Stock Holding History

Menard Financial Group’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,058	Closed	-$412K	–	145
2020 Q4	$412K	Buy	2,058 +782	+61%	+$159K	0.44%	64
2020 Q3	$280K	Buy	+1,276	New	+$270K	0.32%	87

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Menard Financial Group's TDOC Position: Q1 2021 in Review

Menard Financial Group sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 2,058 shares — an estimated $412K sold.

Menard Financial Group first reported a position in TDOC in Q3 2020 and held it in 2 quarters. The position peaked at $412K in Q4 2020. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

Menard Financial Group reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
Menard Financial Group sold 2,058 Teladoc Health shares in Q1 2021, an estimated $412K.
Menard Financial Group first reported a position in Teladoc Health in Q3 2020 and held it in 2 quarters.
Menard Financial Group's Teladoc Health position peaked at $412K in Q4 2020.
890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on Menard Financial Group's 13F filing for Q1 2021, filed 17 May 2021.